The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Toronto, Ontario
Our Toronto facility covers all phases of drug product development from early-phase formulation development to clinical trial material to commercial supply in the same plant using scalable equipment for non-GMP and GMP Work. Our experts at the Toronto facility are ready to address your needs for highly potent, low potent, complex formulations, pediatric dosage forms, patent-extension strategies, as well as conventional oral solid formulations.
Specialized Capabilities
- Oral Disintegrating Tablet (ODT)
- Low Solubility
- Pellet Coating/Pellet Filling
- Roller Compaction
- Bilayer/Microtabletting
- Spray Granulation
- Low Humidity Processing
- High potency manufacturing (Potency Capability up to Cat 3b)
This site features a strong regulatory inspection history from all major international regulatory agencies.
Learn more about the specific equipment and capabilities at this site by downloading our Site Fact Sheet.
2100 Syntex Court
Mississauga, Ontario L5N 7K9, Canada